Providing solutions for product development, clinical research, and contract manufacturing in the pharmaceutical and biopharmaceutical industries.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: May 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Cerba Research
A
Providing specialized laboratory services and biotechnology solutions for clinical research, pharmaceutical industry, and public health organizations.
Quotient Sciences
A
Drug development and manufacturing services, including drug product formulation, phase 1 clinical trials, and commercial production.
NextPharma
A
Pharmaceutical development and manufacturing services, including clinical trials, commercial manufacturing, and packaging for pharmaceutical and health & nutrition products.
Initiatives identified among leaders
Intégration de la RSE dans la gouvernance et la rémunération des dirigeants.
“Le groupe Cerba a intégré la responsabilité sociét...” - Cerba ResearchStratégie ESG alignée sur ODD, Pacte Mondial et réduction des émissions.
“Quotient Sciences a mis en place une stratégie ESG...” - Quotient SciencesTransition vers des énergies renouvelables et suivi des progrès pour neutralité carbone d’ici 2025
“NextPharma s’engage à devenir un leader des pratiq...” - NextPharma56% of similar organizations communicate on CSR issues
+582 initiatives collected from 48 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports